Document Detail


Effects of titrated beta blockade (metoprolol) on silent myocardial ischemia in ambulatory patients with coronary artery disease.
MedLine Citation:
PMID:  3630934     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
This study investigates effects of beta-adrenergic blockade on total silent ischemic time assessed by ambulatory electrocardiographic monitoring and its relation to heart rate and time of day in ambulatory men with coronary artery disease. Metoprolol, when titrated to optimal dose in a controlled trial in 9 patients, reduced both total silent ischemic time (from 156 +/- 65 to 20 +/- 15 minutes, p = 0.04) and frequency of silent ischemic episodes (from 8 +/- 2 to 2 +/- 2 episodes, p = 0.03) compared with placebo. Mean daily heart rate was reduced, from 82 +/- 2 beats/min during placebo to 58 +/- 1 beats/min, as was heart rate at onset of 1 mm of ST-segment depression (106 +/- 2 to 74 +/- 4 beats/min, both p less than 0.001). Heart rate increased 10 +/- 1 beats/min during silent ischemia with placebo therapy, but increased only 4 +/- 1 beats/min during metoprolol treatment (p less than 0.03). During placebo administration the largest proportion of silent ischemic time occurred between 0600 and 1200 hours. Metoprolol attenuated this circadian variation in silent ischemia while reducing (p less than 0.05) total silent ischemic time in all periods. Thus, beta-adrenergic blockade reduces the frequency of silent myocardial ischemic episodes and total silent ischemic time, while mean daily heart rate and heart rate at onset of ischemia and maximal ischemia decrease. Metoprolol treatment also attenuates circadian variation of silent ischemia. These data may be interpreted to suggest that beta-adrenergic activation operates in the pathogenesis of silent myocardial ischemia and its circadian variation.
Authors:
G A Imperi; C R Lambert; K Coy; L Lopez; C J Pepine
Related Documents :
23511434 - Systemic accident analysis of deaths due to failed björk-shiley heart valves.
332374 - Detection of myocardial ischemia.
9626844 - Circadian blood pressure changes and myocardial ischemia in hypertensive patients with ...
1666054 - Prolonged period of global ischemia causes no change in the gtp-binding proteins in the...
21919964 - Retrograde delivery of stem cells: promising delivery strategy for myocardial regenerat...
16245494 - An audit of anticoagulation practice among uk cardiothoracic consultant surgeons follow...
Publication Detail:
Type:  Clinical Trial; Comparative Study; Controlled Clinical Trial; Journal Article    
Journal Detail:
Title:  The American journal of cardiology     Volume:  60     ISSN:  0002-9149     ISO Abbreviation:  Am. J. Cardiol.     Publication Date:  1987 Sep 
Date Detail:
Created Date:  1987-10-19     Completed Date:  1987-10-19     Revised Date:  2006-11-15    
Medline Journal Info:
Nlm Unique ID:  0207277     Medline TA:  Am J Cardiol     Country:  UNITED STATES    
Other Details:
Languages:  eng     Pagination:  519-24     Citation Subset:  AIM; IM    
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Aged
Circadian Rhythm / drug effects
Coronary Disease / drug therapy*,  physiopathology
Double-Blind Method
Electrocardiography
Heart Rate / drug effects
Humans
Male
Metoprolol / therapeutic use*
Monitoring, Physiologic
Placebos
Random Allocation
Time Factors
Chemical
Reg. No./Substance:
0/Placebos; 37350-58-6/Metoprolol

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Usefulness of a high-dose dipyridamole-echocardiography test for diagnosis of syndrome X.
Next Document:  Validation of a real-time electrocardiographic monitor for detection of myocardial ischemia secondar...